Literature DB >> 1984129

The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group.

L T Goodnough1, M F Johnston, P T Toy.   

Abstract

We audited 540 patients undergoing elective first-time coronary artery bypass grafts at 18 institutions. The purposes of the study were to describe the variability in transfusions among institutions and to determine factors that may account for variability. Mean homologous red blood cell use per patient was 2.9(+/- 0.1) U (institutional range, 0.4 to 6.3 U). One hundred seventy-seven patients (32%) received plasma (institutional range, 0% to 97%), and 119 (22%) received platelets (institutional range, 0% to 80%). After controlling for patient and surgical practice variables, transfusion practice factors still accounted for variation in red blood cell transfusions. Variation in patients receiving plasma and platelet transfusions among institutions was determined in part by prophylactic transfusions. We conclude that blood component usage for coronary artery bypass grafts differs widely among institutions. The variability in use of these components is accounted for in part by unnecessary transfusions in otherwise routine, uncomplicated coronary artery bypass graft procedures.

Entities:  

Mesh:

Year:  1991        PMID: 1984129

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.

Authors:  J F Hardy; S Bélisle
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

2.  Clinical decision support and improved blood use in patient blood management.

Authors:  Lawrence Tim Goodnough; Marie A Hollenhorst
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Blood bank audit.

Authors:  P H Pinkerton
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Cardiac surgical patients must not be denied the benefits of autologous blood predonation.

Authors:  J F Hardy; S Bélisle; F Décary
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

5.  Surgeon and Facility Variation in the Use of Minimally Invasive Breast Biopsy in Texas.

Authors:  Nina P Tamirisa; Kristin M Sheffield; Abhishek D Parmar; Christopher J Zimmermann; Deepak Adhikari; Gabriela M Vargas; Yong-Fang Kuo; James S Goodwin; Taylor S Riall
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

Review 6.  Component therapy.

Authors:  K M Radhakrishnan; Srikumar Chakravarthi; S Pushkala; J Jayaraju
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

Review 7.  Natural and synthetic antifibrinolytics in cardiac surgery.

Authors:  J F Hardy; J Desroches
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

8.  Autologous blood donation in support of cardiac surgery: a preliminary report on a hospital-based autologous donor programme.

Authors:  P H Pinkerton
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

9.  Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Authors:  Elsayed M Elmistekawy; Lee Errett; Hosam F Fawzy
Journal:  J Cardiothorac Surg       Date:  2009-05-07       Impact factor: 1.637

10.  Hospital variation in transfusion and infection after cardiac surgery: a cohort study.

Authors:  Mary A M Rogers; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Brahmajee K Nallamothu
Journal:  BMC Med       Date:  2009-07-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.